Company Filing History:
2 out of 45 
1 out of 28 
1 out of 3 Years Active: 2002-2005
Title: Roger W. Graham: Innovator in Cancer Therapy
Introduction
Roger W. Graham is a notable inventor based in Vancouver, Canada. He has made significant contributions to the field of cancer therapy through his innovative approaches. With a total of three patents to his name, Graham's work focuses on enhancing the efficiency of cancer treatments.
Latest Patents
Graham's latest patents include groundbreaking methods for combination therapy using nucleic acids and conventional drugs. This invention relates to methods for increasing the efficiency of transformation of cycling cells. The methods involve synchronizing cells at a first stage of the cell cycle and transforming the cells at a second stage with a genetically engineered nucleic acid that encodes a desired gene product. This invention is particularly relevant to cancer therapy, as it aims to efficiently transform cancer cells with nucleic acids that encode gene products that inhibit the growth of cancer cells. Another significant patent by Graham is for combination therapy using nucleic acids and radiotherapy, which shares similar methodologies and objectives in enhancing cancer treatment.
Career Highlights
Throughout his career, Roger W. Graham has worked with prominent companies in the biotherapeutics sector. He has been associated with Protiva Biotherapeutics, Inc. and Inex Pharmaceuticals Corporation, where he contributed to the development of innovative cancer therapies. His work has been instrumental in advancing the understanding and treatment of cancer.
Collaborations
Graham has collaborated with notable professionals in the field, including Phalgun Joshi and Ian Maclachlan. These collaborations have further enriched his research and development efforts in cancer therapy.
Conclusion
Roger W. Graham's contributions to cancer therapy through his innovative patents and collaborations highlight his commitment to improving treatment outcomes for patients. His work continues to inspire advancements in the field of biotherapeutics.